Pliant Therapeutics, Inc. Common Stock
Symbol: PLRX (NASDAQ)
1.81
▲ (11.04%) 0.180
Company Description:
Pliant Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovering and developing novel therapies for the treatment of fibrosis and related diseases. Its primary product candidate is bexotegrast (PLN-74809), an oral, small molecule, that the company is developing for the treatment of idiopathic pulmonary fibrosis, or IPF, and primary sclerosing cholangitis.
Key Stats
- Today's Open: $1.62
- Today's High: $1.885
- Today's Low: $1.62
- Today's Volume: 3.43M
- Yesterday Close: $1.63
- Yesterday High: $1.71
- Yesterday Low: $1.6
- Yesterday Volume: 228.34K
- Last Min Volume: 15
- Last Min High: $1.81
- Last Min Low: $1.81
- Last Min VWAP: $1.81
Company Profile
- Name: Pliant Therapeutics, Inc. Common Stock
- Website: https://www.pliantrx.com
- Listed Date: 2020-06-03
- Location: SOUTH SAN FRANCISCO, CA
- Market Status: Active
- CIK Number: 0001746473
- SIC Code: 2834
- SIC description: PHARMACEUTICAL PREPARATIONS
- Market Cap: $114.18M
- Round Lot: 100
- Outstanding Shares: 61.39M
- Asset Type: CS
RECENT FILINGS FOR PLRX
| Filing Date | Filing Type | Format |
|---|---|---|
| 2025-09-04 | SCHEDULE 13G | View |
| 2025-08-14 | SCHEDULE 13G/A | View |
| 2025-08-07 | 10-Q | View |
| 2025-08-07 | 8-K | View |
| 2025-08-06 | SCHEDULE 13G | View |
| 2025-07-29 | SCHEDULE 13G/A | View |
| 2025-07-17 | SCHEDULE 13G/A | View |
| 2025-06-09 | 4 | View |
| 2025-06-09 | 4 | View |
| 2025-06-09 | 4 | View |
| 2025-06-09 | 4 | View |
| 2025-06-09 | 4 | View |
| 2025-06-09 | 4 | View |
| 2025-06-09 | 4 | View |
| 2025-06-09 | 4 | View |
| 2025-06-09 | 4 | View |
| 2025-06-09 | 8-K | View |
| 2025-05-15 | SCHEDULE 13G/A | View |
| 2025-05-14 | SCHEDULE 13G/A | View |
| 2025-05-08 | 10-Q | View |
Latest News on PLRX